The role of GSK‐3 in synaptic plasticity

Glycogen synthase kinase‐3 (GSK‐3), an important component of the glycogen metabolism pathway, is highly expressed in the CNS. It has been implicated in major neurological disorders including Alzheimer's disease, schizophrenia and bipolar disorders. Despite its central role in these conditions it was not known until recently whether GSK‐3 has neuronal‐specific functions under normal conditions. However recent work has shown that GSK‐3 is involved in the regulation of, and cross‐talk between, two major forms of synaptic plasticity, N‐methyl‐D‐aspartate receptor (NMDAR)‐dependent long‐term potentiation (LTP) and NMDAR‐dependent long‐term depression (LTD). The present article summarizes this recent work and discusses its potential relevance to the treatment of neurological disorders.

[1]  J. Woodgett,et al.  Modulation of the glycogen synthase kinase‐3 family by tyrosine phosphorylation. , 1993, The EMBO journal.

[2]  H. Manji,et al.  Glycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs , 2005, Neuropsychopharmacology.

[3]  Jesus Avila,et al.  Role of tau protein in both physiological and pathological conditions. , 2004, Physiological reviews.

[4]  J. Meador-Woodruff,et al.  Abnormal Glutamate Receptor Expression in the Medial Temporal Lobe in Schizophrenia and Mood Disorders , 2007, Neuropsychopharmacology.

[5]  György Buzsáki,et al.  Synaptic Plasticity in the Hippocampus , 1988, Springer Berlin Heidelberg.

[6]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[7]  K. Deisseroth,et al.  L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons , 1999, Nature.

[8]  G. Pigino,et al.  A novel CDK5‐dependent pathway for regulating GSK3 activity and kinesin‐driven motility in neurons , 2004, The EMBO journal.

[9]  Y. Rao,et al.  Both the Establishment and the Maintenance of Neuronal Polarity Require Active Mechanisms Critical Roles of GSK-3β and Its Upstream Regulators , 2005, Cell.

[10]  P. Cohen,et al.  GSK3 takes centre stage more than 20 years after its discovery. , 2001, The Biochemical journal.

[11]  Andrea Caricasole,et al.  Induction of the Wnt Inhibitor, Dickkopf‐1, Is Associated with Neurodegeneration Related to Temporal Lobe Epilepsy , 2007, Epilepsia.

[12]  G. Collingridge,et al.  Kainate receptors are involved in synaptic plasticity , 1999, Nature.

[13]  P. Cohen,et al.  Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. , 1980, European journal of biochemistry.

[14]  C. Shaw,et al.  Lithium Therapy Improves Neurological Function and Hippocampal Dendritic Arborization in a Spinocerebellar Ataxia Type 1 Mouse Model , 2007, PLoS Medicine.

[15]  Jesús Avila,et al.  Glycogen synthase kinase 3: a drug target for CNS therapies , 2004, Journal of neurochemistry.

[16]  G. Collingridge,et al.  Excitatory amino acids in synaptic transmission in the Schaffer collateral‐commissural pathway of the rat hippocampus. , 1983, The Journal of physiology.

[17]  K. Leroy,et al.  Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. , 1999, Journal of chemical neuroanatomy.

[18]  J. Woodgett,et al.  Glycogen synthase kinase-3: properties, functions, and regulation. , 2001, Chemical reviews.

[19]  F. Plattner,et al.  The Roles of Cyclin-dependent Kinase 5 and Glycogen Synthase Kinase 3 in Tau Hyperphosphorylation* , 2006, Journal of Biological Chemistry.

[20]  H. Manji,et al.  Modulation of Synaptic Plasticity by Antimanic Agents: The Role of AMPA Glutamate Receptor Subunit 1 Synaptic Expression , 2004, The Journal of Neuroscience.

[21]  J. Lambert,et al.  Effects of new non‐N‐methyl‐D‐aspartate antagonists on synaptic transmission in the in vitro rat hippocampus. , 1989, The Journal of physiology.

[22]  Y. Kuroda,et al.  Extracellular adenosine 5′-triphosphate plus activation of glutamatergic receptors induces long-term potentiation in CA1 neurons of guinea pig hippocampal slices , 1999, Neuroscience Letters.

[23]  J. Woodgett,et al.  Molecular cloning and expression of glycogen synthase kinase‐3/factor A. , 1990, The EMBO journal.

[24]  G. Collingridge,et al.  Roles of metabotropic glutamate receptors in LTP and LTD in , 1999, Current Opinion in Neurobiology.

[25]  R. Belmaker,et al.  GSK-3 and the neurodevelopmental hypothesis of schizophrenia , 2002, European Neuropsychopharmacology.

[26]  G. Mills,et al.  Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Youngchul Kim,et al.  Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS , 2007, Experimental Neurology.

[28]  G. Collingridge,et al.  Long-term potentiation of NMDA receptor-mediated synaptic transmission in the hippocampus , 1991, Nature.

[29]  Flávio Kapczinski,et al.  The role of hippocampus in the pathophysiology of bipolar disorder , 2007, Behavioural pharmacology.

[30]  C. W. Scott,et al.  Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Leist,et al.  Efficacy of small‐molecule glycogen synthase kinase‐3 inhibitors in the postnatal rat model of tau hyperphosphorylation , 2007, British journal of pharmacology.

[32]  吉村 武.  GSK-3β regulates phosphorylation of CRMP-2 and neuronal polarity , 2005 .

[33]  T. Bliss,et al.  The Hippocampus Book , 2006 .

[34]  S. Hsu,et al.  Glycogen Synthase Kinase-3β Regulates Presenilin 1 C-terminal Fragment Levels* , 2001, The Journal of Biological Chemistry.

[35]  R. Jope,et al.  The multifaceted roles of glycogen synthase kinase 3β in cellular signaling , 2001, Progress in Neurobiology.

[36]  M. Bear,et al.  Long-term depression in hippocampus. , 1996, Annual review of neuroscience.

[37]  C. Cotman,et al.  Long-term potentiation of guinea pig mossy fiber responses is not blocked by N-methyl d-aspartate antagonists , 1986, Neuroscience Letters.

[38]  M. Bear,et al.  Metaplasticity: the plasticity of synaptic plasticity , 1996, Trends in Neurosciences.

[39]  J. Lucas,et al.  Spatial learning deficit in transgenic mice that conditionally over‐express GSK‐3β in the brain but do not form tau filaments , 2002, Journal of neurochemistry.

[40]  J. Woodgett,et al.  Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. , 1992, The Journal of biological chemistry.

[41]  G. Collingridge,et al.  LTP Inhibits LTD in the Hippocampus via Regulation of GSK3β , 2007, Neuron.

[42]  K. Imahori,et al.  Localization and developmental changes of tau protein kinase I/glycogen synthase kinase-3 beta in rat brain. , 1994, Journal of neurochemistry.

[43]  J. Ávila,et al.  Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease. , 2002, Bipolar disorders.

[44]  A. Harwood,et al.  Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. , 2001, Biochemical and biophysical research communications.

[45]  C. Beasley,et al.  Glycogen synthase kinase-3β immunoreactivity is reduced in the prefrontal cortex in schizophrenia , 2001, Neuroscience Letters.

[46]  K. Imahori,et al.  Localization and Developmental Changes of τ Protein Kinase I/Glycogen Synthase Kinase‐3β in Rat Brain , 1994 .

[47]  D. Melton,et al.  A molecular mechanism for the effect of lithium on development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Z. Bortolotto,et al.  The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity , 1998, Neuropharmacology.

[49]  R. Malenka,et al.  An essential role for protein phosphatases in hippocampal long-term depression. , 1993, Science.

[50]  A. Harwood,et al.  Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited , 2005, Molecular Psychiatry.

[51]  T. Bliss,et al.  Glycogen synthase kinase‐3 inhibition is integral to long‐term potentiation , 2007, The European journal of neuroscience.

[52]  P. Cohen,et al.  Glycogen synthase kinase-3 from rabbit skeletal muscle. , 2005, Methods in enzymology.

[53]  G. Collingridge,et al.  Metabotropic glutamate receptors contribute to the induction of long-term depression in the CA1 region of the hippocampus. , 1993, European journal of pharmacology.

[54]  K. Kaibuchi,et al.  GSK-3β Regulates Phosphorylation of CRMP-2 and Neuronal Polarity , 2005, Cell.

[55]  Hiroshi Kato,et al.  Reversal of long-term potentiation (depotentiation) induced by tetanus stimulation of the input to CA1 neurons of guinea pig hippocampal slices , 1991, Brain Research.

[56]  Fang Liu,et al.  Activation of PI3-Kinase Is Required for AMPA Receptor Insertion during LTP of mEPSCs in Cultured Hippocampal Neurons , 2003, Neuron.

[57]  D. Manahan‐Vaughan,et al.  Requirement of Translation But Not Transcription for the Maintenance of Long-Term Depression in the CA1 Region of Freely Moving Rats , 2000, The Journal of Neuroscience.

[58]  H. Eldar-Finkelman,et al.  Glycogen synthase kinase 3: an emerging therapeutic target. , 2002, Trends in molecular medicine.

[59]  U. Kang,et al.  Membrane Depolarization Induces the Undulating Phosphorylation/Dephosphorylation of Glycogen Synthase Kinase 3β, and This Dephosphorylation Involves Protein Phosphatases 2A and 2B in SH-SY5Y Human Neuroblastoma Cells* , 2005, Journal of Biological Chemistry.

[60]  J. Woodgett,et al.  Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase , 1992, Neuroscience Letters.

[61]  R. Malenka,et al.  Mechanisms underlying induction of homosynaptic long-term depression in area CA1 of the hippocampus , 1992, Neuron.

[62]  Zhen Yan,et al.  Glycogen Synthase Kinase 3 Regulates N-Methyl-d-aspartate Receptor Channel Trafficking and Function in Cortical Neurons , 2007, Molecular Pharmacology.

[63]  H. Manji,et al.  The Anticonvulsants Lamotrigine, Riluzole, and Valproate Differentially Regulate AMPA Receptor Membrane Localization: Relationship to Clinical Effects in Mood Disorders , 2007, Neuropsychopharmacology.

[64]  B. Doble,et al.  GSK-3: tricks of the trade for a multi-tasking kinase , 2003, Journal of Cell Science.

[65]  S. Siegelbaum,et al.  Postsynaptic induction and presynaptic expression of hippocampal long-term depression. , 1994, Science.

[66]  M. Bear,et al.  Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-D-aspartate receptor blockade. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[67]  M. Hetman,et al.  A Positive Feedback Loop between Glycogen Synthase Kinase 3β and Protein Phosphatase 1 after Stimulation of NR2B NMDA Receptors in Forebrain Neurons* , 2005, Journal of Biological Chemistry.

[68]  B. Anderton,et al.  Alzheimer's disease: Clues from flies and worms , 1999, Current Biology.

[69]  N. Wood,et al.  Chronic lithium chloride treatment has variable effects on motor behaviour and survival of mice transgenic for the Huntington’s disease mutation , 2003, Brain Research Bulletin.

[70]  J. Brion,et al.  Developmental expression and localization of glycogen synthase kinase-3β in rat brain , 1999, Journal of Chemical Neuroanatomy.

[71]  R. Malenka,et al.  Involvement of a calcineurin/ inhibitor-1 phosphatase cascade in hippocampal long-term depression , 1994, Nature.

[72]  G. Collingridge,et al.  Role of excitatory amino acid receptors in synaptic transmission in area CA1 of rat hippocampus , 1989, Proceedings of the Royal Society of London. B. Biological Sciences.